home.aspx

 
.

4TH ANNUAL ADVANCES IN IMMUNO-ONCOLOGY UK CONGRESS

May 20-21, 2019
London, UK (United Kingdom)
SHARESHARESHARE
A revamped programme for 2019 ensures you gain a comprehensive look at immuno-oncology drug development from early discovery through to the clinic, featuring key therapeutic strategies such as T-cell therapies, adoptive cell transfer, checkpoint inhibitors, and oncolytic viral therapies. Benefit further from case studies on the delivery of personalized immuno-therapy and genomic approaches, as well as formulation and CMC considerations.